March 20, 2019 at 3:55 pm

Antibiotics and the Elderly

The elderly are increasingly being prescribed antibiotics that can negatively impact mental health. “One of the most common problems for older adults are changes in mental status — getting anxious, getting loopy,” says Dr. Sara Cosgrove, medical director of the Johns Hopkins Hospital’s Adult Antimicrobial Stewardship Program.
For more info, see: https://www.nytimes.com/2019/03/15/health/antibiotics-elderly-risks.html?action=click&module=Discovery&pgtype=Homepage
March 18, 2019 at 2:37 pm

Zoloft can Cause Heart Problems

Adverse drug effects from SSRIs can include heart problems. MISSD encourages close communication between prescribers and patients whenever stopping, starting or changing medication dosage or type.
For more info, see: https://www.birminghammail.co.uk/news/health/fears-common-anti-depressant-sertraline-15989824
March 15, 2019 at 3:58 pm

Upcoming Event: Grief & Loss Workshop Offered Cosponsored by MISSD

MISSD is pleased to partner with No Shame on U and Jewish Family Community Services, Chicago, to present a meaningful workshop for those touched by suicide. The event is open to all and will feature a small-group setting to discuss how grief can manifest itself after a suicide death. We will also explore effective strategies for coping. Participants will be given time to share their experiences and learn from others who have gone through the same type of loss.
To register, please contact Elizabeth Siegel Cohen, LCSW, FT at JCFS Chicago at (847) 745-5404 or elizabethcohen@jcfs.org
March 14, 2019 at 2:00 pm

Tapering is Needed When Stopping Drugs Labeled Antidepressants

MISSD is pleased to see research supporting the need for close monitoring when discontinuing SSRIs such as Prozac, Zoloft and Paxil. Consumers should work closely with their prescribers to carefully taper drug dosage.
For more info, see https://inews.co.uk/news/citalopram-sertraline-people-coming-off-antidepressants-quickly/
March 13, 2019 at 5:59 pm

Interim Chief is Selected for FDA

Director of the National Cancer Institute and a career scientist, Norman “Ned” Sharpless, is named as interim head of the Food and Drug Administration.
For more info, see http://fortune.com/2019/03/12/fda-interim-chief-lifetime-scientist-nci-director-ned-sharpless/
March 7, 2019 at 2:39 pm

FDA Head Abruptly Resigns

Scott Gottlieb, U.S. Food and Drug Administration Commissioner, recently resigned his position. Gottlieb stated he is resigning because he wants to spend more time with his family.
See: https://www.reuters.com/article/us-usa-fda-gottlieb/fda-chief-gottlieb-resigns-idUSKCN1QM2GZ
March 6, 2019 at 12:52 pm

Drugs Labeled Antidepressants May be Hard to Quit

New research shows doctors can misunderstand and misdiagnose withdrawal symptoms when patients try to stop taking SSRIs such as Paxil, Zoloft and Prozac. Insomnia, lack of appetite and increased anxiety can be symptoms of withdrawal that doctors mistake as signs of other illnesses.
For more info, see: https://www.nytimes.com/2019/03/05/health/depression-withdrawal-drugs.html?action=click&module=Well&pgtype=Homepage&section=Health
March 1, 2019 at 2:23 pm

Former FDA Commissioner Notes Agency’s Role in the Opioid Epidemic

A recent 60 Minutes news program features former FDA commissioner discussing the FDA’s mistakes regarding the opioid epidemic.
See https://www.cbsnews.com/news/former-fda-commissioner-says-agency-erred-in-allowing-drug-companies-to-promote-opioids-for-long-term-use-60-minutes/?fbclid=IwAR2mpwSSD8foJJFiINQm-Voz4xFFjKwWwrZPsOhEKC6hZXgU0U_mBCwHZGU